iSELECT FUND

Investing at the Nexus of Food and Health

Business Model:

Revenue: $1M

Employees: 11-50

Rankings

Detailed iSELECT FUND Information

Geographic Data

iSELECT FUND headquarters map

Address: 1401 South Brentwood Boulevard

City: Saint Louis

State: MO

Zip: 63144

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$14M

Metrics

5,224,699Website Global Rank

1,752Website Monthly Traffic

Twitter Followers

Description

The iSELECT FUND provides accredited clients of financial advisors with access to a diversified portfolio of promising early-stage private ventures that have been evaluated by an elite committee of accomplished entrepreneurs and venture investors.

Contact Phone:
+13142198688

Contact Email:

iSELECT FUND went public on 9/30/2021 on the NYSE

Listed Exchange:
NYSE

IPO Date:
9/30/2021

Ticker Symbol:
BHIL

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
7/2018 HerdDogg Seed Round 3M
1/2018 Artemis Corporate Round 1.5M
5/2022 Vestaron Series C 0
12/2017 Bonumose Series A 3.3M
8/2019 Benson Hill Series C 0
8/2013 Time To Cater Angel Round -
9/2016 Kultevat Venture Round -
7/2014 CrazyForEducation Seed Round -
4/2014 adFreeq Angel Round -
5/2018 Entac Medical Series A -
11/2014 Gremlin Social Seed Round 500k
5/2023 Pluton Biosciences Series A 0
4/2022 ImmunoPhotonics Series B 0
2/2014 Tansna Therapeutics Seed Round 850k
4/2015 Bractlet Seed Round 750k
12/2015 Open Studio Network Seed Round -
7/2020 Biosense Seed Round 0
3/2021 Pattern Ag Venture Round -
10/2019 Molecular Assemblies Series A 0
5/2014 adFreeq Seed Round -
5/2021 Kula Bio Seed Round 0
9/2017 Agrible Series B 0
9/2022 Bond Pet Foods Series A 0
9/2021 Flywheel.io Series C 0
8/2014 Benson Hill Seed Round 0
5/2017 Benson Hill Series B 25M
2/2022 Harpe Bio Venture Round 3M
2/2022 Harpe Bio Convertible Note 3.2M
9/2013 Tansna Therapeutics Angel Round -
9/2015 BenchmarkONE Seed Round 1.4M
1/2022 Kula Bio Series A 0
4/2015 BenchmarkONE Venture Round -
12/2016 Euclises Pharmaceuticals Venture Round 1.2M
11/2019 Mobilion Systems Series A 15.4M
2/2014 Time To Cater Angel Round 102.5k
1/2015 Kultevat Venture Round -
4/2023 Mercy BioAnalytics Series A 0
10/2015 Mentor Spaces Seed Round 1.3M
12/2021 Cyrus Biotechnology Series B 0
4/2021 Molecular Assemblies Series A 0
12/2016 Honcho Seed Round 850k
9/2020 TradeLanes Seed 4M
6/2021 Sentera Series C 0
2/2023 Growers Edge Series B 0
1/2015 ImmunoPhotonics Series A 600k
1/2017 Holganix Venture Round 0
5/2016 Neuros Medical Venture Round 6M
9/2016 Bractlet Venture Round 2M
5/2019 Artemis Series A 8M
10/2015 Antegrin Therapeutics Seed Round 800k
1/2023 EarthOptics Series B 0
9/2014 ImmunoPhotonics Series A 1.8M
9/2015 Euclises Pharmaceuticals Venture Round 0
8/2016 Epharmix Seed Round -
7/2014 Time To Cater Seed Round -
6/2016 StreamLink Software Venture Round 10M
8/2022 Pattern Ag Series B 35M
7/2020 Geltor Series B 0
3/2022 Molecular Assemblies Series B 0
10/2020 Benson Hill Series D 0
9/2017 Cofactor Genomics Series A 18M
9/2018 Benson Hill Series C 65M
7/2017 PopBookings Venture Round 1M
5/2018 Shield Bio Series A 0
4/2015 Ward Alternative Energy Venture Round -
3/2021 Stony Creek Colors Series B 9M
8/2022 Vestaron Series C 0
5/2020 BCD Bioscience Series A 0
10/2022 AgriWebb Series B 6.3M
9/2021 EarthOptics Series A 10.3M
4/2022 BCD Bioscience Series A 0
4/2022 BCD Bioscience Series A 0
4/2022 ImmunoPhotonics Series B 0
3/2022 Molecular Assemblies Series B 0
2/2022 Harpe Bio Series A 0
1/2022 Kula Bio Series A 0
12/2021 Cyrus Biotechnology Series B 0
9/2021 Flywheel.io Series C 0
6/2021 Sentera Series C 0
5/2021 Kula Bio Seed Round 0
4/2021 Molecular Assemblies Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research